Pharmaceuticals

Global Anti-Inflammatory Therapeutics Market 2025–2029: Competitive Insights and Opportunities

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Anti-Inflammatory Therapeutics Industry By The Forecast Year 2029?

The anti-inflammatory therapeutics market has seen consistent expansion in recent years. It is anticipated to increase from $114.71 billion in 2024 to $117.28 billion in 2025, achieving a compound annual growth rate (CAGR) of 2.2%. The historical growth of this market can be linked to the widespread occurrence of chronic illnesses, an aging global population, heightened public awareness, and supportive government initiatives.

The anti-inflammatory therapeutics market is projected to experience consistent expansion over the upcoming years, with its size anticipated to reach $142.15 billion by 2029, driven by a compound annual growth rate (CAGR) of 4.9%. This growth throughout the forecast period can be attributed to the emergence of innovative therapies, increasing healthcare expenditure, a heightened focus on rare diseases, and the development of biologics and biosimilars. Significant trends expected during this period include advancements in immunotherapy, the integration of artificial intelligence (AI) and machine learning (ML) into drug discovery, and the expansion of therapeutic indications.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp

What Are The Main Drivers Boosting The Anti-Inflammatory Therapeutics Industry’s Expansion?

The expanding prevalence of inflammatory bowel disease is projected to boost the future growth of the anti-inflammatory therapeutics market. Inflammatory bowel disease (IBD) is a long-term condition that causes inflammation in the gastrointestinal tract. Anti-inflammatory therapeutics are essential in treating Crohn’s disease by decreasing inflammation, alleviating symptoms, and lessening the need for surgery. As an illustration, in July 2023, Oxford University Press (OUP), the academic publisher of the University of Oxford, reported that the incidence of inflammatory bowel disease (IBD) was 10.9 per 100,000 person-years, and the prevalence stood at 721 per 100,000 people. This rise in inflammatory bowel disease prevalence is, therefore, a key driver for the growth of the anti-inflammatory therapeutics market.

How Is The Anti-Inflammatory Therapeutics Market Segmented?

The anti-inflammatory therapeutics market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics

2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen

2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone

3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins

What Are The Major Trends Driving The Growth Of The Anti-Inflammatory Therapeutics Market?

Key players within the anti-inflammatory therapeutics market are rolling out innovative drugs to bolster their market standing. For example, in February 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, in collaboration with Sanofi, a France-based pharmaceutical and healthcare company, unveiled Kevzara (sarilumab). This product is notable as the first and only anti-inflammatory biologic recommended for adult patients diagnosed with polymyalgia rheumatic (PMR), an inflammatory rheumatic condition, particularly those who do not adequately respond to corticosteroids or are unable to endure corticosteroid tapering.

Which Global Market Leaders Are Shaping The Future Of The Anti-Inflammatory Therapeutics Sector?

Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Anti-Inflammatory Therapeutics Market?

North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Anti-Inflammatory Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp

Browse Through More Reports Similar to the Global Anti-Inflammatory Therapeutics Market 2025, By The Business Research Company

Inflammatory Bowel Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Non Steroidal Anti Inflammatory Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Cystic Fibrosis Cf Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cystic-fibrosis-cf-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795